Greenway Greenhouse Cannabis Corporation (CSE:GWAY)
Canada · Delayed Price · Currency is CAD 0.1600
0.00 (0.00%)
At close: Feb 4, 2026
CSE:GWAY Revenue
Greenway Greenhouse Cannabis had revenue of 2.09M CAD in the quarter ending September 30, 2025, with 15.81% growth. This brings the company's revenue in the last twelve months to 8.46M, up 19.66% year-over-year. In the fiscal year ending March 31, 2025, Greenway Greenhouse Cannabis had annual revenue of 8.95M with 71.10% growth.
Revenue (ttm)
8.46M
Revenue Growth
+19.66%
P/S Ratio
2.51
Revenue / Employee
n/a
Employees
10
Market Cap
21.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 8.95M | 3.72M | 71.10% |
| Mar 31, 2024 | 5.23M | -391.74K | -6.97% |
| Mar 31, 2023 | 5.62M | 3.64M | 183.32% |
| Mar 31, 2022 | 1.98M | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| iAnthus Capital Holdings | 209.79M |
| 1CM Inc. | 75.01M |
| Rubicon Organics | 57.19M |
| MediPharm Labs | 46.10M |
| Simply Solventless Concentrates | 33.70M |
| Avicanna | 25.50M |
| PharmaCielo | 2.27M |